Trial Profile
A Blinded Crossover Study of the 24 Hour Blood Pressure Response to Treatment of Obstructive Sleep Apnea Associated Hypertension With Nebivolol or Hydrochlorothiazide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2020
Price :
$35
*
At a glance
- Drugs Hydrochlorothiazide (Primary) ; Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 20 May 2016 Status changed from active, no longer recruiting to completed.
- 21 Mar 2016 New trial record